Roivant Sciences Ltd. (NASDAQ: ROIV) reported Q3 non-GAAP EPS of ($0.42), $0.05 worse than the analyst estimate of ($0.37). Revenue for the quarter came in at $17.05 million versus the consensus estimate of $14.11 million.

For earnings history and earnings-related data on Roivant Sciences Ltd. (ROIV) click here.